Correa, Ricardo Amorim http://orcid.org/0000-0003-1779-0443
Arancibia, Francisco http://orcid.org/0000-0001-5429-5420
De Ávila Kfouri, Renato http://orcid.org/0000-0002-3903-8140
Chebabo, Alberto http://orcid.org/0000-0003-4557-2662
García, Gabriel http://orcid.org/0000-0002-4268-4960
Gutiérrez Robledo, Luis Miguel http://orcid.org/0000-0002-9728-6644
Lopardo, Gustavo http://orcid.org/0000-0002-0886-2380
Nemerovsky, Julio http://orcid.org/0009-0006-4869-738X
Pérez, Carlos M. http://orcid.org/0000-0002-9210-7854
Rendon, Adrian http://orcid.org/0000-0001-8973-4024
Ruiz-Palacios, Guillermo M. http://orcid.org/0000-0003-3708-9654
Aggarwal, Bhumika http://orcid.org/0000-0002-8370-9319
Berzanskis, Arnas http://orcid.org/0009-0005-5456-405X
Cintra, Otavio http://orcid.org/0000-0002-3485-8780
Funding for this research was provided by:
GlaxoSmithKline Biologicals
Article History
Received: 19 December 2023
Accepted: 12 January 2024
First Online: 15 February 2024
Declarations
:
: Bhumika Aggarwal, Arnas Berzanskis, and Otavio Cintra: employees and stock owners of GSK. Francisco Arancibia: received payment of honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from OM-Pharma and Pfizer; participated on a Data Safety Monitoring Board or Advisory Board for OM-Pharma and GSK; and had a leadership of fiduciary role in other board, society, committee, or advocacy group, paid or unpaid, for ALAT (President). Alberto Chebabo: received grants or contracts from Pfizer; payment of honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from GSK, Pfizer, MSD, and Takeda; support for attending meetings and/or travel from Pfizer and Takeda; and participated on a Data Safety Monitoring Board or Advisory Board for GSK, Takeda, and Pfizer. Ricardo Amorim Correa: received grants or contracts from Janssen, MSD, and Bayer; consulting fees from Janssen, MSD, and Bayer; payment of honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Janssen and Bayer; payment for expert testimony from Janssen, MSD, and Bayer; support for attending meetings and/or travel from AstraZeneca and Bayer; and had a leadership of fiduciary role in other board, society, committee, or advocacy group, paid or unpaid, for SBPT (President Elect). Gabriel García: received payment of honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from GSK, Boehringer Ingelheim, Novartis, Sanofi, and Chiesi. Luis Miguel Gutiérrez Robledo: received grants or contracts from GSK; consulting fees from GSK; payment of honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from GSK; support for attending meetings and/or travel from Sanofi; participated on an Advisory Board for GSK. Renato De Ávila Kfouri: received grants or contracts from Pfizer; consulting fees from Pfizer, GSK, Sanofi, MSD, Takeda, and Moderna; payment of honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Pfizer, GSK, Takeda, Sanofi, AstraZeneca, and MSD; support for attending meetings and/or travel from Pfizer and Sanofi; participated on a Data Safety Monitoring Board or Advisory Board for Clover Vaccines; and had a leadership of fiduciary role in other board, society, committee, or advocacy group, paid or unpaid, for Sociedade Brasileira de Pediatria (Pres do Depto Immunization), Sociedade Brasileira De Imunizações (Vice President), and NITAG Brasil (member). Gustavo Lopardo: received grants or contracts from MSD; consulting fees from GSK and Pfizer; and support for attending meetings and/or travel from Pfizer. Julio Nemerovsky: received grants or contracts from GSK; payment of honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from GSK and Casasco; support for attending meetings and/or travel from Baliarda; and participated on a Data Safety Monitoring Board or Advisory Board for GSK. Carlos M. Pérez: received grants or contracts from Merck and Sinovac to institution; consulting fees from GSK/ViiV; payment of honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from GSK/ViiV, Pfizer, and Gador; support for attending meetings and/or travel from Pfizer and Gador; and participated on a Data Safety Monitoring Board or Advisory Board for GSK/ViiV. Adrian Rendon: received grants or contracts from Pfizer and Boehringer Ingelheim; payment of honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from GSK, AstraZeneca, Chiesi, and Sanofi; support for attending meetings and/or travel from GSK and AstraZeneca; and participated on a Data Safety Monitoring Board or Advisory Board for GSK. Guillermo M. Ruiz-Palacios: participated on a Data Safety Monitoring Board or Advisory Board for GSK.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.